John Edwards, a U.S. presidential candidate, would apparently ban drug ads targeted at consumers for 2 years. This type of advertising by pharmaceutical companies is called direct-to-consumer (DTC) advertising in the industry, and it pays well because pharmaceutical companies recognize the value in getting their brand names in front of the right audiences.
Why does John Edwards want such pharmaceutical advertising banned for the first 2 years after a new drug is released?
“You’ve seen these ads. You know who’s paying for them, right? You are,” Edwards said yesterday at a speech in New Hampshire, the AP reported. He added that the ads are “driving up demand for the most expensive and most profitable drugs.”
Okay, but isn’t that an argument for, well, any company that advertises? I mean, cars would be cheaper if all the automobile manufacturers stopped advertising. Food prices would also decrease, according to his logic, if large food companies stopped all their advertising.
The problem is, of course, that little thing we have in America we call the 1st Amendment. Advertising traditionally falls under the cover of protected “free speech” in the U.S. So banning such ads for a specific period of time would likely come under heavy legal fire and be tied up in the courts for years.
Danny Carlat, M.D., has a different take on DTC ads — he actually likes them (see What’s Wrong with DTC Ads?).
I tend to agree… I think the potential for benefits in terms of educating people about possible and usually common ills outweighs their annoyance factor or whatever small bump in prescriptions such marketing gives the drug.
You can leave a response, or trackback from your own site.
Links to This Article
Direct-to-Consumer Drug Advertising | Political news - democrats republicans socialists greens liberals conservatives (10/29/2007)
University Update - John Edwards - Direct-to-Consumer Drug Advertising (10/29/2007)
Direct Marketing » Direct-to-Consumer Drug Advertising (10/30/2007)
3 Comments to
“Direct-to-Consumer Drug Advertising”
I don’t think that drug companies should be allowed to advertise either to the consumer or to a professional audience.
Advertising techniques are based on ‘rhetoric’ (emotional persuasion) rather than evidence and reason and I think that serious medication decisions should be based on evidence and reason rather than on rhetoric. The thing with advertising is that we aren’t even aware of how it effects us (studies have shown us that). Who would have thought that our choice of which brand of spaghetti sauce to buy was made on the basis of product placement. Who would have thought that our (or our doctors) choice of which medication to try was based on the cute puppy that looks just like the cute puppy that the wonderful neighbours down the road have!
The interpretation of the first amendment is controversial, I guess, though I hear you when you say there is precedent for regarding advertising to be protected “free speech”. What does it matter if medication decisions are based on cute puppies rather than evidence and reason? How is medication different from spaghetti sauce? What if the person with the urinary problem would spontaneously come right in 6 months without treatment whereas taking the treatment results in his experiencing a severe side-effect? How do we weigh whether it is better to treat another 100 people with the drug when (say) 5 of those people have serious side effects that they never would have had if the drug hadn’t been marketed?
The trouble I have is that advertisements DO have dubious claims that are undersupported by evidence. If someone says that ‘this brand of spaghetti sauce is America’s favourite brand’ then do they get in trouble if someone does a study whereby it is found not to be? Drug companies purposely didn’t ask people about sexual side effects for SSRI’s and they purposely kept the side effect estimate several magnitudes lower than they were found to be when people actually got around to doing the studies.
I think that health matters more than spaghetti sauce… And that freedom of speech has to be tempered with the effects of ones speech on others (e.g., you can’t yell bomb on the plane) and I really don’t think… You should pursuade people to make serious health decisions on the basis of emotion rather than evidence and reason.
DTC (direct-to-consumer) Advertising is one of the most controversial practices the drug industry uses to market its various products.
Total spending on pharmaceutical promotion grew from $11.4 billion in 1996 to $29.9 billion in 2005. Although during that time spending on direct-to-consumer advertising increased by 330%, it made up only 14% of total promotional expenditures in 2005. Direct-to-consumer campaigns generally begin within a year after the approval of a product by the FDA.
Supporters of this form of advertising, which is banned in nearly almost all countries (excluding the United States and New Zealand) say it provides a real service to consumers, informing them of new drugs and alerting them to health problems they may be unaware of.
Critics feel this form of advertising promotes only the most expensive new blockbuster drugs, when older and cheaper versions of drugs might be just as effective, thus driving up overall health care costs, with much emphasis placed on the high costs of prescription drugs.
Aggressive promotion can pay off big time. Merck, maker of Vioxx, the most promoted drug, spent $161 million advertising it in 2000, and sales of Vioxx quadrupled to $1.5 billion.
In fact, Merck spent more advertising Vioxx, according to NIHCM (National Institute for Health Care Management Foundation), than the $125 million spent promoting Pepsi or the $146 million spent on Budweiser beer ads. It even came close to the $169 million spent promoting GM’s Saturn, the nation’s most advertised car.
The drug industry says its ads not only educate consumers but also prompt people who might otherwise go undiagnosed to see their doctors. Many doctors agree.
What’s your opinion as to whether or not prescription drug advertising costs are a direct reflection to the high costs of prescription drugs in the United States.
First someone invented new holidays so we would send more greeting cards and now they are inventing new diseases that require new drugs. I’ve seen ads on TV for Caduet. It has two ingredients. One is Amlodipine and the other is Atorvastatin. With my RxDrugCard I can get 30 tablets of Amlodipine for $9 and 30 tablets of Simvastatin for $9. I’ll bet they are charging more than $18 for this new drug! The unthinking public is going to pressure their doctors into giving them something just because it’s new, when something old or generic would do the job for cheaper.
Join the Conversation! Post a Comment:
Last reviewed: By John M. Grohol, Psy.D. on 29 Oct 2007





(3 votes, average: 3.67 out of 5)

